The Nasdaq-listed biotechnology firm is raising $425 million for its ETH strategy, joining a parade of penny stocks investing in cryptocurrencies as their business flounders.
Votre partenaire sûr dans la croissance de la richesse cryptographique
Contacts
Tower Ten, 20th floor, Strawinskylaan 1665, 1077 XX Amsterdam
+4367762309684
support@cashorba.com
Du lundi au vendredi : 9h00 - 17h00